Newman Brian 4

What Happened

• Brian Newman, a director of Colgate-Palmolive Co. (CL), was credited with 210 shares (recorded as an acquisition/award) on April 1, 2026.
• The unit price reported was $89.05 per share, for a total value of $18,701. This was an award/deferral of compensation, not an open-market purchase or sale.

Key Details

• Transaction date and price: April 1, 2026 — 210 shares at $89.05 each (total $18,701).
• Transaction type/code: A (Grant, award or other acquisition).
• Shares owned after transaction: Not disclosed in this Form 4.
• Footnote: The shares were the portion of an annual cash retainer deferred to a stock unit account under the Deferred Compensation Plan for Non-Employee Directors (Footnote F1).
• Filing timeliness: Reported on April 3, 2026 for the April 1 transaction — appears timely (no late filing indicated).

Context

• These are deferred stock units credited under a director compensation plan, a routine form of non-employee director pay. Such deferred awards typically track the company's share value but may be subject to plan settlement rules and are distinct from an open-market buy or a sale.